PolyNovo is redefining the healing of complex wounds through its proprietary NovoSorb® biodegradable polymer technology, featured in NovoSorb MTX and NovoSorb BTM (Biodegradable Temporising Matrix). With over 70,000 patients treated across indications including vascular wounds, skin cancers, burns, and trauma, PolyNovo is committed to expanding access to innovative care. The company continues to invest in advanced wound healing programs that empower clinicians to deliver world-class outcomes.